Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
A Review on Hematologic Malignant Patients Infected With 2019 Novel Coronavirus Publisher



Lotfali E1 ; Ghasemi R2 ; Mardani M3 ; Fattahi A4 ; Rezaei K2 ; Toreyhi H2 ; Abolghasemi S3
Authors

Source: Archives of Clinical Infectious Diseases Published:2020


Abstract

Since late 2019, when novel coronavirus pneumonia emerged in China and spread worldwide, there has been a need for data con-cerning the clinical characteristics of infected immunocompromised patients. It has been reported that a significant mortality rate occurs in individuals with underlying comorbidities such as hematologic malignancies. Therefore, it is vital to illustrate the clinical manifestations and outcomes of COVID-19 in these vulnerable patients and identify safe therapeutic strategies. This study reviewed the clinical course, laboratory findings, and risk factors associated with hematologic malignant patients with COVID-19 along with the management and therapeutic regimens. © 2020, Author(s).
Related Docs
View other Related Docs
1. Challenges Posed by Covid-19 in Cancer Patients: A Narrative Review, Cancer Medicine (2022)
2. A Review on Currently Available Potential Therapeutic Options for Covid-19, International Journal of General Medicine (2020)
3. Pharmacological Treatments of Covid-19, Pharmacological Reports (2020)
Experts (# of related papers)
View all Related Experts
Nima Rezaei (5)
Elaheh Malakan Rad (1)
Other Related Docs
4. Cancer Care Management During the Covid-19 Pandemic, Risk Management and Healthcare Policy (2020)
5. Sars-Cov-2: Current Trends in Emerging Variants, Pathogenesis, Immune Responses, Potential Therapeutic, and Vaccine Development Strategies, International Immunopharmacology (2021)
6. Covid-19 in Patients With Cancer: Risks and Precautions, American Journal of Emergency Medicine (2021)
7. How Prevalent Is Cancer in Confirmed Cases With Coronaviruses and Severe Acute Respiratory Syndromes?, Advances in Experimental Medicine and Biology (2021)
8. Interleukin-6 and Severe Covid-19: A Systematic Review and Meta-Analysis, European Cytokine Network (2020)
9. Immunology, Immunopathogenesis and Immunotherapeutics of Covid-19; an Overview, International Immunopharmacology (2021)
10. Covid-19: Our Current Knowledge of Epidemiology, Pathology, Therapeutic Approaches, and Diagnostic Methods, Anti-Cancer Agents in Medicinal Chemistry (2021)
11. The Prognostic Value of Comorbidity for the Severity of Covid-19: A Systematic Review and Meta-Analysis Study, PLoS ONE (2021)
12. Chest-Ct Findings of Covid-19 in Patients With Pre-Existing Malignancies; a Pictorial Review, Clinical Imaging (2020)
13. The Clinical Value of Two Combination Regimens in the Management of Patients Suffering From Covid-19 Pneumonia: A Single Centered, Retrospective, Observational Study, DARU# Journal of Pharmaceutical Sciences (2020)
14. Novel Therapeutic Approaches for Treatment of Covid-19, Journal of Molecular Medicine (2020)
15. Clinical Symptoms and Types of Samples Are Critical Factors for the Molecular Diagnosis of Symptomatic Covid-19 Patients: A Systematic Literature Review, International Journal of Microbiology (2021)
16. Immune-Epidemiological Parameters of the Novel Coronavirus–A Perspective, Expert Review of Clinical Immunology (2020)
17. Covid-19 in Patients With Cancer, Advances in Experimental Medicine and Biology (2021)
18. Covid-19: A Systematic Review and Update on Prevention, Diagnosis, and Treatment, MedComm (2022)
19. Cardiovascular Disease in Covid-19: A Systematic Review and Meta-Analysis of 10,898 Patients and Proposal of a Triage Risk Stratification Tool, Egyptian Heart Journal (2020)
20. Classification of the Present Pharmaceutical Agents Based on the Possible Effective Mechanism on the Covid-19 Infection, DARU# Journal of Pharmaceutical Sciences (2020)